EON: Enhanced Online News (press release) NEW YORK--(BUSINESS WIRE)--The Rosen Law Firm is investigating the Board of Directors of China Nuokang Bio-Pharmaceutical Inc. (NASDAQ: NKBP) for possible breaches of fiduciary duty and other violations of corporate law in connection with a going ...
Seeking Alpha Dynavax is a clinical-stage bio-pharmaceutical company with an under development product named "Heplisav" , a vaccine for the prevention of Hepatitis B. In November, 2012, the company received the FDA's advisory committee's report and in February of ... and more »
GSPInsider The development stage bio pharmaceutical company had completed the Phase III clinical trials for its drug candidate AFREZZA, which had been developed as an ultra rapid action meal time insulin inhalation powder. Study 171, which is an open label study ... and more »
WallStreetPR Boston, MA 06/10/2013 (wallstreetpr) - The share prices of Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) had declined by 10.14 percent to close at $1.33 per share for the end of last trading session on Friday. The shares of the company had been ...
Wall Street Journal ... R&D on biological medicines. In the recent several years growing numbers of Chinese pharma and bio-pharma companies have been steadily increasing their investment in innovative drug R&D, including the discovery and development of novel biologics.
